Qi Diagnostics Limited is a leading medical device company specializing in proprietary nanosensor technology that detects volatile organic compounds (VOCs) in human breath for health diagnostics. By combining expertise in biochemical sensor development and advanced sensor applications, Qi Diagnostics creates highly sensitive, selective, and non-invasive breathalyzer devices.
The company's flagship product, KetoAir, applies this nanosensor technology to measure ketone levels in the breath, providing users with accurate metabolic health monitoring and support. KetoAir offers a convenient and radiation-free alternative to traditional diagnostic methods, enabling easier management of metabolic conditions such as diabetes and obesity.
Qi Diagnostics is committed to advancing health innovation through biochemical sensor technology and cutting-edge breath analysis, targeting both clinical and consumer health markets globally.